Logo image of ADK.CA

DIAGNOS INC (ADK.CA) Stock Price, Quote, News and Overview

TSX-V:ADK - TSX Venture Exchange - CA2524423068 - Common Stock - Currency: CAD

0.315  +0 (+0.8%)

ADK.CA Quote, Performance and Key Statistics

DIAGNOS INC

TSX-V:ADK (3/7/2025, 7:00:00 PM)

0.315

+0 (+0.8%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High0.43
52 Week Low0.23
Market Cap31.84M
Shares101.08M
Float87.33M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)07-15 2025-07-15
IPO09-27 2000-09-27


ADK.CA short term performance overview.The bars show the price performance of ADK.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8

ADK.CA long term performance overview.The bars show the price performance of ADK.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 20

The current stock price of ADK.CA is 0.315 CAD. In the past month the price decreased by -3.08%. In the past year, price increased by 12.5%.

DIAGNOS INC / ADK Daily stock chart

ADK.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
KSI.CA KNEAT.COM INC N/A 607.92M
VHI.CA VITALHUB CORP 130 507.60M
KOVO.CA KOVO+ HOLDINGS INC N/A 7.08M
AVCR.CA AVRICORE HEALTH INC N/A 4.05M
EKG.CA CARDIOCOMM SOLUTIONS INC N/A 2.90M

About ADK.CA

Company Profile

ADK logo image Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. The company provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

Company Info

DIAGNOS INC

7005 Taschereau Blvd Suite 340

Brossard QUEBEC J4Z 1A7 CA

CEO: Andre Larente

Employees: 16

Company Website: https://www.diagnos.com/

Investor Relations: http://www.diagnos.ca/cards/Financial_Reports-en-9

Phone: 14506788882

DIAGNOS INC / ADK.CA FAQ

What is the stock price of DIAGNOS INC today?

The current stock price of ADK.CA is 0.315 CAD. The price increased by 0.8% in the last trading session.


What is the ticker symbol for DIAGNOS INC stock?

The exchange symbol of DIAGNOS INC is ADK and it is listed on the TSX Venture Exchange exchange.


On which exchange is ADK.CA stock listed?

ADK.CA stock is listed on the TSX Venture Exchange exchange.


What is the price forecast or stock price prediction for DIAGNOS INC stock?

9 analysts have analysed ADK.CA and the average price target is 1.53 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.315. Check the DIAGNOS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DIAGNOS INC worth?

DIAGNOS INC (ADK.CA) has a market capitalization of 31.84M CAD. This makes ADK.CA a Nano Cap stock.


How many employees does DIAGNOS INC have?

DIAGNOS INC (ADK.CA) currently has 16 employees.


What are the support and resistance levels for DIAGNOS INC (ADK.CA) stock?

DIAGNOS INC (ADK.CA) has a support level at 0.3 and a resistance level at 0.34. Check the full technical report for a detailed analysis of ADK.CA support and resistance levels.


Is DIAGNOS INC (ADK.CA) expected to grow?

The Revenue of DIAGNOS INC (ADK.CA) is expected to grow by 4.67% in the next year. Check the estimates tab for more information on the ADK.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DIAGNOS INC (ADK.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DIAGNOS INC (ADK.CA) stock pay dividends?

ADK.CA does not pay a dividend.


When does DIAGNOS INC (ADK.CA) report earnings?

DIAGNOS INC (ADK.CA) will report earnings on 2025-07-15.


What is the Price/Earnings (PE) ratio of DIAGNOS INC (ADK.CA)?

DIAGNOS INC (ADK.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).


ADK.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA turns out to be only a medium performer in the overall market: it outperformed 42.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ADK.CA Financial Highlights

Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -2.5% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -117.56%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-16.22%
Sales Q2Q%-50.12%
EPS 1Y (TTM)-2.5%
Revenue 1Y (TTM)-35.13%

ADK.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ADK.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of -0.49% and a revenue growth 4.67% for ADK.CA


Ownership
Inst Owners0.01%
Ins Owners5.86%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price Target1.53 (385.71%)
EPS Next Y-0.49%
Revenue Next Year4.67%